A Cautionary Note on Vascular Margins in Keyhole Liver Surgery
A recent editorial in the Annals of Surgical Oncology highlights a critical knowledge gap in minimally invasive liver surgery. The piece, titled “R1 Vascular Margins in Minimally Invasive Liver Surgery: Absence of Evidence is Not Evidence of Equivalence,” argues that the oncologic safety of achieving a microscopically positive vascular margin (R1vasc) during laparoscopic or robotic liver resections has not been definitively proven to be equivalent to outcomes in open surgery. While minimally invasive techniques offer benefits like reduced blood loss and shorter hospital stays, the editorial stresses that the fundamental principle of achieving clear vascular margins for curative intent in surgical oncology must not be compromised. The authors call for rigorous, prospective studies to compare local recurrence and survival rates specifically associated with R1vasc margins across different surgical approaches before assuming parity.
Study Significance: For surgical oncologists and hepatobiliary surgeons, this editorial serves as a vital reminder to prioritize oncologic principles over technical feasibility. It implies that surgical decision-making and training must continue to emphasize the paramount importance of margin status, even as adoption of minimally invasive surgery grows. This perspective should directly influence preoperative planning, intraoperative technique, and the critical evaluation of surgical outcomes in liver tumor resection.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
